Recent advances and problems in primary therapy for cervical cancer in Taiwan

Journal of the Formosan Medical Association

Volumn 103, Issue 7, 2004, Pages 511-518

  Chen, Chen An ^a   Hsieh, Chang Yao ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cervical cancer; Chemotherapy; Radiotherapy; Review; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; VINCRISTINE;

BLOOD TOXICITY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONDYLOMA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; HEALTH CARE ACCESS; HUMAN; META ANALYSIS; MORBIDITY; MULTIMODALITY CANCER THERAPY; PAPANICOLAOU TEST; PATIENT EDUCATION; PREVALENCE; PROGNOSIS; RADICAL HYSTERECTOMY; REVIEW; SYSTEMATIC REVIEW; TAIWAN; UTERINE CERVIX CANCER; WART VIRUS;

FEMALE; HUMANS; MASS SCREENING; NEOPLASM STAGING; PROGNOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 6344287932     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Benedet JL, Odicino F, Maisonneuve P, et al: Carcinoma of the cervix uteri. J Epidemiol Biostat 2001;6:5-44.
2. Munoz N, Bosch FX, de Sanjose S, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
3. Chen TM, Chen CA, Wu CC, et al: The genotypes and prognostic significance of human papillomaviruses in cervical cancer. Int J Cancer 1994;57:181-4.
4. Liaw KL, Hsing AW, Chen CJ, et al: Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer 1995;62:565-71.
5. Chen RJ, Chang DY, Yen ML, et al: Independent clinical factors which correlate with failures in diagnosing early cervical cancer. Gynecol Oncol 1995;58:356-61.
6. Cheng WF, Wei LH, Su YN, et al: The possible use of colour flow Doppler in planning treatment in early invasive carcinoma of the cervix. Br J Obstet Gynaecol 1999;106:1137-42.
7. Hsieh CY, Wu CC, Chen TM, et al: Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color Doppler ultrasound. Cancer 1995;75:2518-22.
8. Sheu M, Chang C, Wang J, et al: MR staging of clinical stage I and IIa cervical carcinoma: a reappraisal of efficacy and pitfalls. Eur J Radiol 2001;38:225-31.
9. Wang LJ, Wong YC, Chen CJ, et al: Cervical carcinoma: MR imaging with integrated endorectal/phased-array coils: a pilot study. Eur Radiol 2001;11:1822-7.
10. Ho CM, Chien TY, Jeng CM, et al: Staging of cervical cancer: comparison between magnetic resonance imaging, computed tomography and pelvic examination under anesthesia. J Formos Med Assoc 1992;91:982-90.
11. Yeh LS, Hung YC, Shen YY, et al: Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings. Oncol Rep 2002;9:1289-92.
12. Lai CH, Huang KG, Hong JH, et al: Randomized trial of surgical staging (extra peritoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol 2003;89:160-7.
13. Chu KK, Chang SD, Chen FP, et al: Laparoscopic surgical staging in cervical cancer - preliminary experience among Chinese. Gynecol Oncol 1997;64:49-53.
14. Su TH, Wang KG, Yang YC, et al: Laparoscopic para-aortic lymph node sampling in the staging of invasive cervical carcinoma: including a comparative study of 21 laparotomy cases. Int J Gynaecol Obstet 1995;49:311-8.
15. Benedet J, Odicino F, Maisonneuve P, et al: Carcinoma of the cervix uteri: FIGO annual report on the results of treatment in gynaecological cancer. J Epidemiol Biostat 1998;3:5-34.
16. Waggoner SE: Cervical cancer. Lancet 2003;361:2217-25.
17. Tanaka Y, Sawada S, Murata T: Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix. Acta Radiol 1984; 23:455-9.
18. Delgado G, Bundy B, Zaino R, et al: Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-7.
19. Tsai CS, Lai CH, Wang CC, et al: The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 1999;75:328-33.
20. Perez CA, Grigsby PW, Chao KS, et al: Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998;41:301-17.
21. Lee YN, Wang KL, Lin MH, et al: Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases. Gynecol Oncol 1989;32:135-42.
22. Chen RJ, Lin YH, Chen CA, et al: Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol 1999;73:184-90.
23. Chou CY, Wang ST, Kuo HC, et al: Serum level of squamous cell carcinoma antigen and tumor size are useful to identify preoperatively patients at high risk of cervical cancer. Cancer 1994;74:2497-501.
24. Lin H, ChangChien CC, Huang EY, et al: The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer. Acta Obstet Gynecol Scand 2000; 79:140-4.
25. Chen CA, Wu CC, Chen TM, et al: Cell kinetics and radiosensitivity of cervical squamous cell carcinoma. Cancer Lett 1994;82:135-40.
26. Lai CH, Hong JH, Hsueh S, et al: Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer 1999;85:1537-46.
27. Cheng WF, Chen CA, Lee CN, et al: Vascular endothelial growth factor and prognosis of cervical carcinoma. Obstet Gynecol 2000; 96:721-6.
28. Cheng WF, Chen CA, Lee CN, et al: Vascular endothelial growth factor in cervical carcinoma. Obstet Gynecol 1999;93:761-5.
29. Yang YC, Chang CL: Modified radical hysterectomy for early Ib cervical cancer. Gynecol Oncol 1999;74:241-4.
30. Lee CL, Huang KG, Jain S, et al: Comparison of laparoscopic and conventional surgery in the treatment of early cervical cancer. J Am Assoc Gynecol Laparosc 2002;9:481-7.
31. Hsieh YY, Lin WC, Chang CC, et al: Laparoscopic radical hysterectomy with low paraaortic, subaortic and pelvic lymphadenectomy. Results of short-term follow-up. J Reprod Med 1998;43:528-34.
32. Tan R, Chung CH, Liu MT et al: Results of postoperative radiotherapy for clinical stage Ib uterine cervical carcinoma with evidence of microscopic involvement of surgical margin, parametrium and/or lymph node metastasis. J Formos Med Assoc 1991;90:836-9.
33. Lin HH, Cheng WF, Chan KW, et al: Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Obstet Gynecol 1996;88:274-9.
34. Yeh SA, Wan Leung S, Wang CJ, et al: Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors. Gynecol Oncol 1999;72:10-5.
35. Hong JH, Tsai CS, Lai CH, et al: Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis. Int J Radiat Oncol Biol Phys 2002;53:1284-90.
36. Peters WA, 3rd, Liu PY, Barrett RJ, 2nd, et al: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18:1606-13.
37. Lai CH, Lin TS, Soong YK, et al: Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol 1989; 35:193-8.
38. Landoni F, Maneo A, Colombo A, et al: Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
39. Liu WS, Yen SH, Chang CH, et al: Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer. Gynecol Oncol 1996;60:295-300.
40. Chen MS, Lin FJ, Hong CH, et al: High-dose-rate afterloading technique in the radiation treatment of uterine cervical cancer: 399 cases and 9 years experience in Taiwan. Int J Radiat Oncol Biol Phys 1991;20:915-9.
41. Chiou JF, Liu MT, Lai YL, et al: High-dose-rate afterloading brachytherapy in carcinoma of the uterine cervix. J Formos Med Assoc 1993;92:165-73.
42. Hsu WL, Wu CJ, Jen YM, et al: Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: a nonrandomized comparison of treatment results. Int J Radiat Oncol Biol Phys 1995;32:1425-31.
43. Wang CJ, Leung SW, Chen HC, et al: High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme. Int J Radiat Oncol Biol Phys 1997;38:391-8.
44. Chen SW, Liang JA, Yang SN, et al: High dose-rate brachytherapy for elderly patients with uterine cervical cancer. Jpn J Clin Oncol 2003;33:221-8.
45. Huang EY, Lin H, Hsu HC, et al: High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Gynecol Oncol 2000;79:406-10.
46. Chen SW, Liang JA, Yang SN, et al: The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2000;47:955-61.
47. Chen SW, Liang JA, Yang SN,et al: The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol 2003;67:69-76.
48. Hopkins MP, Morley GW. Stage IB squamous cell carcinoma of the cervix: clinicopathologic features related to survival. Am J Obstet Gynecol 1991;164:1520-7.
49. Homesely HD, Raben M, Blake DD, et al: Relationship of lesion size to survival in patients with stage IB squamous cell carcinoma of the cervix uteri treated by radiation therapy. Surg Gynecol Obstet 1980;150:529-31.
50. Chang HC, Lai CH, Chou PC, et al: Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma. Cancer Chemother Pharmacol 1992;30:281-5.
51. Chen CA, Cheng WF, Wei LH, et al: Radical hysterectomy alone or combined with neoadjuvant chemotherapy in the treatment of early stage bulky cervical carcinoma. J Formos Med Assoc 2002;101:195-202.
52. Chang TC, Lai CH, Hong JH, et al: Randomized trial of neo-adjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol 2000;18:1740-7.
53. Shueng PW, Hsu WL, Jen YM, et al: Neoadjuvant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 1998;40:889-96.
54. Neoadjuvant chemotherapy for cervical cancer meta-analysis collaboration: Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 2003; 39:2470-86.
55. Keys HM, Bundy BN, Stehman FB, et al: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
56. Chang HC, Lai CH, Chen MS, et al: Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: a pilot study. Gynecol Oncol 1992;44:182-8.
57. Lin JC, Ho ES, Jan JS, et al: High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1996;61:101-8.
58. Hsu WL, Shueng PW, Jen YM, et al: Concurrent 5-fluorouracil, daily low-dose cisplatin, and radiotherapy in stage IIIB cervical cancer. A phase II prospective study. Am J Clin Oncol 1996;19:263-7.
59. Tseng CJ, Chang CT, Lai CH, et al: A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 1997;66:52-8.
60. Rose PG, Bundy BN, Watkins EB, et al: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
61. Green J, Kirwan J, Tierney J, et al: Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2001:CD002225.
62. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347:1645-51.